On December 26^th, 2016, B&E Bio-technology, a subsidiary of B&E Diagnostics Inc., was successfully listed on Qi Lu Equity Exchange Center, which is a regional OTC stock trading market in Shandong Province, China.

B&E Diagnostics is engaged in manufacturing, marketing and sales of hematology analyzers and bio-sensor technology based electrolyte analyzers worldwide. B&E Bio-technology has manufacturing facility and R&D center, and manages Chinese market. Landing on the capital market allows B&E to gain financial support, further enhance its core competitiveness and increase investment in POCT field.